Sudden cardiac arrest deaths in young people have been reported following COVID-19, but there is insufficient evidence to confirm the cause, Union Health Minister Mansukh Mandaviya said Parliament today. Mr Mandaviya responded to a question in the Lok Sabha by saying that the Indian Council of Medical Research is doing three distinct studies to determine the facts about growing incidence of cardiac arrest following the epidemic.
He stated that a multi-centric matched case control study on variables associated with unexpected fatalities among persons aged 18 to 45 is currently underway in India at approximately 40 hospitals/research institutions.
Another multicentric hospital-based matched case control research is now underway at around 30 COVID-19 clinical registry hospitals in India to investigate the effect of the Covid vaccination on thrombotic events in people aged 18 to 45 in 2022.
Another study is also underway to determine the reason of sudden unexplained deaths in young people using virtual and actual autopsies, according to Mandaviya.
The Centre’s Department of Health and Family Welfare provides technical and financial assistance to states and union territories under the National Programme for Prevention and Control of Noncommunicable Diseases (NP-NCD) to address cardiovascular disease-related health issues.
Cardiovascular disease is a component of NP-NCD. The programme involves infrastructure development, human resource development, health promotion, and population-based screening of the population in the 30-year and above age group under the Ayushman Bharat Health Wellness Centre, early diagnosis, and management and referral to an appropriate level of health care facility.
Over 60 crore participants receive health insurance coverage of 5 lakh per family per year for secondary or tertiary care hospitalisation under the Pradhan Mantri Jan Arogya Yojana (PMJAY) to allow accessible and inexpensive health care and treatment.
The therapy packages are comprehensive, including all areas of treatment, including medications and diagnostic services. Financial aid is provided to families living below the poverty line for treatment at government hospitals under the Rashtriya Arogya Nidhi umbrella scheme. Furthermore, the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, in conjunction with state governments, makes quality generic medications affordable to all.
